ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNTG Centogene NV

0.48
0.00 (0.00%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 19,900
Bid Price 0.3943
Ask Price 0.4996
News -
Day High 0.50

Low
0.431

52 Week Range

High
2.52

Day Low 0.45
Company Name Stock Ticker Symbol Market Type
Centogene NV CNTG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.48 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.4801 0.45 0.50 0.461 0.48
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
73 19,900 $ 0.4733325 $ 9,419 - 0.431 - 2.52
Last Trade Time Type Quantity Stock Price Currency
16:37:09 formt 500 $ 0.48 USD

Centogene NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
12.97M 27.60M - 66.93M -31.84M -1.15 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Centogene NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CNTG Message Board. Create One! See More Posts on CNTG Message Board See More Message Board Posts

Historical CNTG Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.500.54980.4310.4693737125,324-0.02-4.00%
1 Month0.680.750.4310.6105131127,474-0.20-29.41%
3 Months1.151.23580.4310.66614962,580-0.67-58.26%
6 Months1.02531.530.4310.885876443,782-0.5453-53.18%
1 Year0.732.520.4311.43539,409-0.25-34.25%
3 Years10.9111.950.4311.92198,205-10.43-95.60%
5 Years14.1036.000.4313.81160,363-13.62-96.60%

Centogene NV Description

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.

Your Recent History

Delayed Upgrade Clock